Public shareholder BC Investments is set to sell 45.5 lakh shares or a 2.4% stake in Emcure Pharmaceuticals Ltd. through a block deal on Friday, according to sources.
The offer price is set to be Rs 1,225 per share, which is a 4% discount on the current market price of Rs 1,279.8. The offer size is Rs 551 crore.
Kotak Securities will be the book runners for the deal, the sources said.
Shares of Emcure closed 0.72% higher at Rs 1,279.8 apiece on the National Stock Exchange, compared with a 0.19% decline in the benchmark Nifty. The stock has risen 26.96% in the last 12 months and fallen 11.56% on a year-to-date basis.
Out of the three analysts tracking the company, two maintain a 'buy' rating on the stock and one recommends a 'hold', according to Bloomberg data. The average of 12-month analysts' price target implies a potential downside of 13.9%.
RECOMMENDED FOR YOU
United Spirits Shares Downgraded To 'Sell' By Dolat Capital, Cuts Target Price — Here's Why
Jul 02, 2025
Torrent Expects JB Pharma Deal To Reach Completion Over 15-18 Months
Jul 01, 2025
Capital Group Buys 12% Stake In 360 One WAM For Rs 245 Crore
Jun 26, 2025
Hindustan Zinc Block Deal: Vedanta Offers 1.6% Equity For Rs 3,018 Crore
Jun 17, 2025
POPULAR